
Goldman Sachs' venture capital and private equity strategy emphasizes active, control-oriented ownership to transform acquired companies and accelerate value creation. The firm leverages its extensive global network and thematic investing approach to identify differentiated investment opportunities across various sectors and stages of the corporate lifecycle, increasingly focusing on expanding access to private markets for wealthy individuals and institutional clients.
Deal activity decreased year-over-year (7 deals in the last 12 months vs 12 prior). Average disclosed round size is $178.5M (across 247 rounds with reported amounts).
Portfolio
261
Fund Size
$7B
Top Stage
Series C
Last 12 Mo
7
Team
Mathew McDermott
Managing Partner
Jason Kreuziger
Managing Director
Simone Verri
Partner and CEO of Kinea
Jo Natauri
Global Head of Healthcare Investing
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
Portfolio
| Company | Round | Amount | Date |
|---|---|---|---|
| GGeneral Tensor | Seed | $5M | Mar 2026 |
| Series C | $70M | Feb 2026 | |
| Series E | $425M | Jan 2026 | |
| Series E | $240M | Dec 2025 | |
| Series G | $500M | Nov 2025 | |
| Series E | $135M | Jun 2025 | |
| Series C | $75M | May 2025 | |
| Growth | $45M | Mar 2025 | |
| 773 Strings | Series B | $55M | Feb 2025 |
| Series B | $48.5M | Jan 2025 | |
| Series A | $11M | Nov 2024 | |
| Series C | $75M | Nov 2024 | |
| Growth | $650M | Oct 2024 | |
| Growth | $50M | Oct 2024 | |
| Growth | $100M | Sep 2024 | |
| Growth | $212M | Aug 2024 | |
| Series C | $150M | Jul 2024 | |
| Series F | $900M | Jul 2024 | |
| GGo Digit | Series D | $141M | May 2024 |
| Series B | $55M | Feb 2024 | |
| Series C | $44M | Jan 2024 | |
| Series E | $118M | Dec 2023 | |
| Series B | $45M | Nov 2023 | |
| Series E | $150M | Sep 2023 | |
| RRapport Therapeutics | Series B | $150M | Aug 2023 |
Top Co-Investors
Last updated: 15 April 2026